Pingyuan Wang

4.1k total citations
109 papers, 3.0k citations indexed

About

Pingyuan Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Pingyuan Wang has authored 109 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 24 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Pingyuan Wang's work include Mitochondrial Function and Pathology (15 papers), Cancer, Hypoxia, and Metabolism (14 papers) and Cancer-related Molecular Pathways (10 papers). Pingyuan Wang is often cited by papers focused on Mitochondrial Function and Pathology (15 papers), Cancer, Hypoxia, and Metabolism (14 papers) and Cancer-related Molecular Pathways (10 papers). Pingyuan Wang collaborates with scholars based in United States, China and South Korea. Pingyuan Wang's co-authors include Paul M. Hwang, Jia Zhou, Richard G.W. Anderson, Jian Weng, Zhiqing Liu, Haiying Chen, Ju‐Gyeong Kang, Robert S. Munford, Wenzhe Ma and Bing Tian and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Pingyuan Wang

102 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pingyuan Wang United States 31 1.8k 623 367 290 289 109 3.0k
Yue Huang China 34 2.1k 1.2× 744 1.2× 330 0.9× 256 0.9× 229 0.8× 101 3.6k
Yanjie Zhang China 26 1.7k 0.9× 412 0.7× 458 1.2× 266 0.9× 207 0.7× 87 2.9k
Yanli Zhang China 34 2.0k 1.1× 624 1.0× 963 2.6× 416 1.4× 165 0.6× 283 4.2k
Yingxin Zhao United States 34 1.9k 1.0× 353 0.6× 337 0.9× 470 1.6× 312 1.1× 86 3.0k
Daniele Vergara Italy 31 1.6k 0.9× 601 1.0× 585 1.6× 229 0.8× 182 0.6× 105 3.4k
Qing Xiao China 26 2.0k 1.1× 572 0.9× 744 2.0× 316 1.1× 122 0.4× 87 3.7k
Wenhong Fan United States 31 1.6k 0.9× 547 0.9× 602 1.6× 252 0.9× 88 0.3× 69 2.8k
Stefano Marini Italy 29 1.0k 0.6× 376 0.6× 401 1.1× 163 0.6× 389 1.3× 103 2.3k
Chengcheng Zhang China 32 2.2k 1.2× 699 1.1× 647 1.8× 367 1.3× 206 0.7× 185 4.1k
Ovidio Bussolati Italy 39 2.1k 1.2× 808 1.3× 497 1.4× 242 0.8× 427 1.5× 163 4.8k

Countries citing papers authored by Pingyuan Wang

Since Specialization
Citations

This map shows the geographic impact of Pingyuan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingyuan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingyuan Wang more than expected).

Fields of papers citing papers by Pingyuan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pingyuan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingyuan Wang. The network helps show where Pingyuan Wang may publish in the future.

Co-authorship network of co-authors of Pingyuan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Pingyuan Wang. A scholar is included among the top collaborators of Pingyuan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pingyuan Wang. Pingyuan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Jin, et al.. (2025). Mitochondrial innate immune signaling in skeletal muscle adaptation to exercise. Trends in Endocrinology and Metabolism. 37(2). 115–123.
2.
Nilson, Ashley N., et al.. (2025). Functionally Selective Dopamine D1 Receptor Endocytosis and Signaling by Catechol and Noncatechol Agonists. Biochemistry. 64(7). 1572–1588.
3.
Wang, Pingyuan, et al.. (2024). Orphan GPR52 as an emerging neurotherapeutic target. Drug Discovery Today. 29(4). 103922–103922. 9 indexed citations
4.
Xia, Shuli, et al.. (2023). Semi-Synthesis and Biological Evaluation of 25(R)-26-Acetoxy-3β,5α-Dihydroxycholest-6-One. Marine Drugs. 21(3). 191–191. 4 indexed citations
5.
Wang, Pingyuan, et al.. (2023). Opportunities and challenges in drug discovery targeting the orphan receptor GPR12. Drug Discovery Today. 28(9). 103698–103698. 7 indexed citations
6.
Wang, Pingyuan, Jia Zhou, Pasquale Maffia, et al.. (2022). Protein interaction, cytotoxic, transcriptomic and proteomic responses to structurally distinct EPAC1 activators in HUVECs. Scientific Reports. 12(1). 16505–16505. 4 indexed citations
7.
Wang, Pingyuan, Dharini van der Hoeven, Na Ye, et al.. (2021). Scaffold repurposing of fendiline: Identification of potent KRAS plasma membrane localization inhibitors. European Journal of Medicinal Chemistry. 217. 113381–113381. 8 indexed citations
8.
Liu, Gang, Hye‐Jin Kim, Pingyuan Wang, et al.. (2021). Further lead optimization on Bax activators: Design, synthesis and pharmacological evaluation of 2-fluoro-fluorene derivatives for the treatment of breast cancer. European Journal of Medicinal Chemistry. 219. 113427–113427. 8 indexed citations
9.
Wang, Pingyuan, Jin Ma, Jie Li, et al.. (2020). Reducing Fatty Acid Oxidation Improves Cancer-free Survival in a Mouse Model of Li-Fraumeni Syndrome. Cancer Prevention Research. 14(1). 31–40. 6 indexed citations
10.
Kang, Ju‐Gyeong, Cory U. Lago, Ji‐Eun Lee, et al.. (2020). A Mouse Homolog of a Human TP53 Germline Mutation Reveals a Lipolytic Activity of p53. Cell Reports. 30(3). 783–792.e5. 17 indexed citations
11.
Park, Jihoon, Jie Li, Matthew F. Starost, et al.. (2018). Mouse Homolog of the Human TP53 R337H Mutation Reveals Its Role in Tumorigenesis. Cancer Research. 78(18). 5375–5383. 20 indexed citations
12.
Liu, Zhiqing, A.K. Singh, Haiying Chen, et al.. (2018). Identification of peptidomimetics as novel chemical probes modulating fibroblast growth factor 14 (FGF14) and voltage-gated sodium channel 1.6 (Nav1.6) protein-protein interactions. Bioorganic & Medicinal Chemistry Letters. 29(3). 413–419. 9 indexed citations
13.
Liu, Zhiqing, Bing Tian, Haiying Chen, et al.. (2018). Discovery of potent and selective BRD4 inhibitors capable of blocking TLR3-induced acute airway inflammation. European Journal of Medicinal Chemistry. 151. 450–461. 73 indexed citations
14.
Wang, Pingyuan, Zhiqing Liu, Haiying Chen, et al.. (2017). Exchange proteins directly activated by cAMP (EPACs): Emerging therapeutic targets. Bioorganic & Medicinal Chemistry Letters. 27(8). 1633–1639. 37 indexed citations
15.
Bouchard, Claude, Lígia M. Antunes‐Correa, Euan A. Ashley, et al.. (2014). Personalized Preventive Medicine: Genetics and the Response to Regular Exercise in Preventive Interventions. Progress in Cardiovascular Diseases. 57(4). 337–346. 48 indexed citations
16.
Zhuang, Jie, Pingyuan Wang, Xinglu Huang, et al.. (2013). Mitochondrial disulfide relay mediates translocation of p53 and partitions its subcellular activity. Proceedings of the National Academy of Sciences. 110(43). 17356–17361. 65 indexed citations
17.
Wang, Pingyuan, Wenzhe Ma, Joon‐Young Park, et al.. (2013). Increased Oxidative Metabolism in the Li–Fraumeni Syndrome. New England Journal of Medicine. 368(11). 1027–1032. 100 indexed citations
18.
Wang, Pingyuan, Jie Zhuang, & Paul M. Hwang. (2011). p53. Current Opinion in Oncology. 24(1). 76–82. 24 indexed citations
19.
Wang, Pingyuan, et al.. (1994). Interaction of the interdigitated DPPG or DPPG/DMPC bilayer with human erythrocyte band 3: differential scanning calorimetry and fluorescence studies. Chemistry and Physics of Lipids. 69(3). 241–249. 4 indexed citations
20.
Wang, Pingyuan, et al.. (1993). Anisodamine causes acyl chain interdigitation in phosphatidylglycerol. FEBS Letters. 332(1-2). 193–196. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026